.jpg)
Artificial Intelligence (AI) has transformed the healthcare industry, but the quickly developing technology might make its biggest impact on one of medicine’s greatest fights: cancer.
AI emerges as a formidable ally to doctors and health providers, reshaping the landscape of oncology. Its transformative potential spans from early detection to personalized treatment and patient support. As we delve deeper into the integration of AI in cancer care, it becomes evident that the convergence of technology and medicine holds immense promise in the fight against this pervasive disease.
AI's Role in Cancer Detection and Treatment Optimization
Artificial intelligence is a game-changer in cancer detection, leveraging machine learning algorithms to analyze medical images with unprecedented precision. These AI-driven tools, honed through extensive training on diverse datasets, excel at identifying subtle anomalies that might evade human detection. By scrutinizing mammograms, CT scans, and MRI images, AI can flag suspicious lesions or tumors, enabling early intervention when treatment is most effective.
"The more we can do gradually to move cancer treatment to an earlier stage where it's detected earlier and treated earlier, that would be a major change in the way we deal with the cancer problem," said Dr. Chris Sander, professor in residence of cell biology at Harvard Medical School and co-investigator of a study using AI to detect pancreatic cancer.
In the study, solely using patients' medical records, the AI tool was able to identify those at the highest risk of pancreatic cancer up to three years before an actual diagnosis. "Most pancreatic cancers just present much too late and therefore, patients have a very, very bad survival, which is why we're working on this," Sander said. "Less than 20% survive, but if you see it, then the five-year survival goes up to 50%. If you see it, you can cut it out."
Imagine changing those odds across the board of cancer diagnoses. The traditional approach to diagnosing cancer primarily revolved around biopsy, histological examinations under microscopes, and imaging tests such as MRI, CT, and PET scans. With these traditional approaches, the interpretation of imaging results could vary among professionals, and specific diagnostic procedures can be invasive or uncomfortable. AI significantly improves cancer detection accuracy, reducing false negatives by analyzing these medical images. Using large sets of patient data, AI can potentially identify patients at higher risk for specific types of cancer, such as breast and skin cancer, because of family history, obesity, exposure to workplace hazards, or other health factors, allowing for early screenings. AI projects like Google’s DeepMind and PathAI aid in diagnosing diseases, including cancer, surpassing human capabilities in spotting anomalies.
What’s more, AI and machine-based learning predict patient responses to cancer treatments, prioritizing drugs and improving treatment outcomes. Researchers at UC San Francisco, for example, have developed a virtual molecular library to encode commands for engineered immune cells, enabling them to effectively seek out and destroy cancer cells without taking breaks. This means more personalized and targeted chemotherapy and immunotherapy treatments for each and every patient.
Beyond diagnosis and treatment, AI plays a pivotal role in supporting patients throughout their cancer journey. Innovative solutions like AI chatbots provide personalized guidance and support, addressing the multifaceted challenges faced by individuals undergoing treatment. These virtual companions offer timely reminders for medication adherence, educational resources, and empathetic support to alleviate anxiety and uncertainty. Moreover, AI-powered platforms facilitate seamless communication between patients and healthcare providers, fostering a collaborative environment where concerns can be addressed promptly and treatment plans adjusted as needed.
The Potential Drawbacks of AI’s Involvement in Cancer Care
While the integration of AI in cancer care holds immense promise, it is not without its challenges. One notable concern revolves around the issue of overdiagnosis, wherein AI-driven tools may flag abnormalities that, while detectable, may not necessarily pose an immediate threat to the patient's health.
"If you're on the lookout for something, then, if you look in enough places, you'll start to see it," said Dr. Brittany Fasy, an associate professor of computational topology at Montana State University. "So, I think how and when to use computer-assisted diagnosis is an important conversation that needs to happen between clinicians doing the diagnosis, the researchers developing the methods to assist them, and the patients who it affects the most."
Another significant drawback stems from biases inherent in the data used to train AI algorithms, particularly concerning skin cancer diagnosis in individuals with darker skin tones. Research has shown that AI systems trained on predominantly homogeneous datasets may exhibit reduced accuracy when applied to racially diverse populations, leading to disparities in diagnostic outcomes. Addressing these biases requires concerted efforts to diversify training data and develop algorithms that are robust across different demographic groups.
Furthermore, the reliance on AI for cancer diagnosis and treatment planning raises ethical and regulatory concerns regarding the autonomy of healthcare professionals and the safety of patients. While AI can provide valuable insights and recommendations, ultimately, the decision-making process should remain firmly in the hands of trained clinicians who can contextualize AI-generated data within the broader clinical framework.
"The problem with finding cancer, particularly finding early cancer, is that we have difficulty picking out which cancer is extra destined to progress and grow and metastasize and kill patients versus those cancers that would never be destined to grow progress, and actually harm patients," he said. "The point of cancer detection is not to find more cancer, it is to find more cancer that can potentially kill people and prevent that," he continued. "It's the prevention of cancer death, not finding more cancer."
A study partly conducted by Google in 2020 trained AI to spot breast cancer in mammogram scans. Researchers said the tool was able to do so at the level of—and even better than—a board-certified radiologist. However, past research has shown that not every tumor in a person with cancer will become deadly, and there are many people with cancers that don't lead to death. Striking the right balance between AI-driven decision support and human expertise is essential to ensure the highest standards of patient care and safety.
And that’s where regulation comes—or should come—in. Collaborative efforts between regulatory bodies, healthcare providers, and technology developers are crucial in establishing guidelines for responsible AI deployment in cancer care. The Cancer Moonshot initiative, the ambitious and optimistic project from the U.S. government that aims to reduce cancer-related death rates by 50% by 2047, is one such collaboration across the health, science, and tech sectors.
Conclusion
The history of cancer care shows a continual process of refining treatments; and AI represents the next step. Its transformative impact is felt across every facet of oncology, from early detection to personalized treatment and patient support. While challenges such as data biases and regulatory hurdles persist, the collective efforts of researchers, clinicians, and technologists pave the way for a future where cancer is detected earlier, treated more effectively, and patient outcomes are vastly improved. By embracing responsible AI deployment and fostering collaboration across disciplines, we can realize the vision of a world where cancer is no longer synonymous with despair, but instead, a conquerable foe.
Sources
Discover What Grows Wealth with Minimum Effort & Minimum Risk
